V8Q DEEP DIVE

PRCT — PROCEPT BioRobotics

Robotics / surgical Physical AI

Accepted Sep. 11 archive snapshot.

V8Q SCORE59/100

WATCHARCHIVED CYCLE VERDICT · NOT LIVE

CYCLE PRICE$20.38

DRAWDOWN FROM HIGH-48.5%

21D RS IMPROVEMENT+0.6%

RECOVERY PATHPath A

ARCHIVE SNAPSHOTAccepted V8Q cycle from Sep. 11, 2026. Prices are archived cycle / last-tracked observations, not live quotes.Open closest candidate

Executive Read

The opportunity has to earn the verdict.

PRCT ranked third in the latest accepted snapshot and represented the robotics / surgical Physical AI audit. Stabilization passed and the 20-day slope improved, but price was still below the 20-day average, no higher low was confirmed, accumulation remained weak, and free cash flow was negative. The archived verdict is WATCH.

Research only. Not personalized investment advice.

Recovery Evidence

252-session drawdown-48.5%

21D RS improvement+0.6%

StabilizationPASS

SMA20 slopePositive

Price vs SMA20Below

AccumulationWeak

Text values above are archive-backed for current finalists. Sparklines are decorative UI accents, not price history.

Catalyst Engine

Surgical roboticsDirect robotics exposure was verified in the accepted research cycle.

HYDROS / WATER IVCurrent milestone evidence was part of the catalyst review.

Recovery confirmationThe technical setup still lacked a higher low and clean SMA20 reclaim.

Cash burnNegative free cash flow remains a decisive risk input.

Price & Volume

VISUALIZATION ONLY · STANDARDIZED ARCHIVED PRICE SERIES NOT YET CONNECTED

The report layout keeps the chart position from the approved mockup, but V8Q will not fabricate a historical series. This panel becomes real when the standardized performance ledger is connected.